A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these accounts privately for source information, while also obtaining discount codes.
Additionally, a flourishing market exists on Telegram, where communities with numerous of members share comparison photos, administration instructions and assertions of next-day British shipping. Vendors promote the drug there before directing customers to WhatsApp for purchases.
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Nevertheless, physicians and chemists have cautions that the sale of what remains an unapproved medication in the UK is worrisome and could result in users injecting substances of uncertain source.
Some professionals stated the popularity for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, advertising, and customer regulations, potentially leading to fines, legal action or imprisonment.
According to the social media company, the platform has taken down problematic material and banned related hashtags and query recommendations. The organization stated it was committed to maintaining the service safe and investing in enhancing enforcement strategies.
Investigations also found groups with up to 9,000 members selling retatrutide using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, filled with photos of weight loss, positive reviews and detailed guides for preparing or injecting at home.
Within minutes of entering one group, a seller posted WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.
Within these groups, posts show dark colored parcels with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When asked how much time a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
A spokesperson for Telegram stated it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
“People are injecting substances they can’t verify. Even if the science behind this drug is valid, these online products may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of an online medical service connected the surge in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.
Her team has already encountered patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to possibly serious medical dangers”.
A tech strategist with over a decade of experience in digital innovation and AI-driven solutions, passionate about shaping the future of technology.